Searchable abstracts of presentations at key conferences in endocrinology

ea0005oc7 | Reproduction and Development | BES2003

Metformin is more effective than Dianette in the treatment of hirsutism in women with PCOS

Harborne L , Norman J , Lyall H , Fleming R

Introduction: Polycystic ovary syndrome (PCOS) is associated with insulin resistance and hyperandrogenism. In many cases this leads to hirsutism, for which a common treatment is combined anti-androgen and estrogen therapy (Dianette; Schering Ltd). The insulin sensitising agent metformin has been reported to reduce hyperandrogenism in women with PCOS.The aim of this study was to compare the clinical efficacy of Dianette with metformin (Glucophage; Merck, 500mgs tds) in the ...

ea0003p218 | Reproduction | BES2002

A randomised controlled trial comparing the use of metformin and dianette in hirsutism associated with PCOS

Harborne L , Fleming R , Lyall H , Norman J

Hirsutism in women with polycystic ovary syndrome (PCOS) is associated with hyperandrogenism and insulin resistance. The insulin sensitising agent metformin can reduce hyperandrogenism in women with PCOS. Conventional treatment for hirsutism in such women is combined anti-androgen and estrogen (Dianette; Schering Ltd). The aim of this study was to compare the clinical efficacy of Dianette with metformin (Glucophage; Merck, 500mgs tds) in the treatment of hirsutism in women wit...

ea0056ep151 | Reproductive Endocrinology | ECE2018

Hirsutism in patients with polycystic ovary syndrome

Elfaleh Emna , Oueslati Ibtissem , Rejeb Ons , Chaker Fatma , Chihaoui Melika , Yazidi Meriem , Slimane Hedia

Introduction: Polycystic ovary syndrome (PCOS) is a heterogeneous disorder, characterized by chronic anovulation and hyperandrogenism. Hirsutism, defined as excessive terminal hair that appears in a male pattern in a woman, is frequently present in patients with PCOS. We aimed to determine the clinical and biological characteristics of hirsute patients with PCOS.Methods: It was a retrospective study included 30 women diagnosed with PCOS according to the ...

ea0073aep66 | Adrenal and Cardiovascular Endocrinology | ECE2021

Recurrence of a malignant corticosadrenaloma

Pangui Henricia Laurinda , Haraj Nassim Essabah , Aziz Siham El , Chadli Asmaa

IntroductionThe adrenal cortex is a rare malignant tumor at the expense of the adrenal gland, very aggressive because of its invasion, its metastatic potential and its five (5) year survival at 40% with a high risk of locoregional relapse.Case presentationWe report the case of a 17-year-old patient with a history of long-term corticosteroid therapy over 3 years and secondary amenorrhea for 2 years, who was ad...

ea0075a06 | Adrenal gland | EYES2021

Sinister cause of amenorrhea in adolescent girls – a case series

Boya Harshitha , Selvan Chitra , VSM Suryanaryana , P R Manjunath , Acharya Himamshu , Kolla Bharathi

Background: Hirsutism is a common and disturbing complaint among women attending endocrine clinics. It is caused by androgen excess and when severe, might progress to virilization. Virilizing adrenal tumors are a rare cause of hirsutism.Case presentation: A 14 year old girl presented with primary amenorrhea, poor breast development (Tanner stage B1), hirsutism (Ferriman-gallwey score, FGS of 12/36) clitoromegaly (clitoral index >200 mm2). ...

ea0094p122 | Reproductive Endocrinology | SFEBES2023

Rare case of a steroid cell tumour causing hirsutism in a young girl

Amjad Wajiha , Krishnan Leena

Steroid cell tumours are very rare ovarian sex cord tumours that account for only < 0.1% of ovarian tumours. We present an interesting case of a steroid cell tumour in a 17 year old girl referred with worsening hirsutism, weight gain of nearly 3 stones and oligomenorrhea over 2 years. Menarche with regular menstrual cycles was attained at the age of 13 followed by normal reproductive development. On examination, she had an elevated BMI of 33.7 and there was marked hirsutis...

ea0081p90 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Evening chronotype is associated with hormonal and metabolic disorders in Polycystic Ovary Syndrome

Verde Ludovica , Barrea Luigi , Vetrani Claudia , Docimo Annamaria , De Alteriis Giulia , Savastano Silvia , Colao Annamaria , Muscogiuri Giovanna

Objective: Polycystic ovary syndrome (PCOS) is the most common female endocrine disorder. Recently in the context of obesity, which often coexists with PCOS, it has been highlighted the role of chronotype as risk factor for obesity-related cardiometabolic complications. Given the importance of chronotype categories in the context of metabolic diseases and being PCOS characterized by metabolic derangements, we aimed to investigate the prevalence of chronotype categories in wome...

ea0081p124 | Endocrine-Related Cancer | ECE2022

Hirsutism as the first manifestation of a mesonephric-like adenocarcinoma of the ovary: the first case with positive androgen receptors

Timon Iciar Martin , Ugalde-Abiega Beatriz , Zubillaga Mikaela , Moreno-Ruiz Inmaculada , Huguet Isabel , Meizoso-Pita Olalla , Trivino Yannuzzi Vanessa , Sevillano-Collantes Cristina

Mesonephric adenocarcinoma (MA) is an uncommon gynecologic tumor that are thought to arise from embryonal remnants of the mesonephric ducts, also known as Wolffian ducts. Mesonephric-like adenocarcinoma (MLA), despite absence of Wolffian origin, have similar morphology and immunophenotype and exhibit molecular aberrations like MA. These tumors are generally negative for estrogen and progesterone receptor.Case Report: An 83-year-old Spanish female was ref...

ea0081p444 | Reproductive and Developmental Endocrinology | ECE2022

Use of selective venous vein sampling in postmenopausal women with hyperandrogenism of unclear aetiology

Romero Gregori Ana , Gimenez Olga , Capel Ismael , Subias David , Marcouchi Saad , Costa Laura , Perendreu Juan , Berlanga Eugenio , Rigla Mercedes

Background: Hyperandrogenism is infrequent in menopause, being the most common cause benign pathologies. However, it can also be produced by an ovarian or adrenal tumour. Correct diagnosis and location can be challenging because small lesions may not be visible with modern imaging studies. We report a case of ovarian stromal hyperplasia where selective venous catheterization and hormonal sampling were performed to find the origin of excessive androgen production.<p class="...

ea0081ep33 | Adrenal and Cardiovascular Endocrinology | ECE2022

Large adrenal tumor in paucisymptomatic ACTH – independent Cushing syndrome’s patient – a clinical case

Mohora Maria-Alexandra , Trifanescu Raluca , Andra Caragheorgheopol , Carmen Iordachescu , Dan Hortopan , Poiana Catalina

Background: Cushing’s syndrome is represented by the cummulation of signs and symptoms of excess glucocorticoids and has many potential causes. Approximately 20 percent of all cases are represented by ACTH-independent adrenal tumors – with a majority of these being represented by cortisol secreting adrenal adenomas. Generally, a large adrenal tumor has over 5 cm in diameter and the risk of it being malignant raises proportionately with the dimensions. Large adrenal t...